BG Medicine this week appointed Eric Bouvier as president and CEO. He replaces Pieter Muntendam, who has moved to the role of executive vice president and chief medical officer.
Bouvier was previously head of BioMérieux’s immunoassay business. Before that he was president of Leica Microsystems, a unit of Danaher.
Sera Prognostics this week appointed Jay Boniface vice president of research and development.